Journal profile · MEDICAL LABORATORY TECHNOLOGY

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

ISSN 0325-2957 · eISSN 1851-6114 · FEDERACION BIOQUIMICA PROVINCIA BUENOS AIRES · ARGENTINA · Quarterly · Founded 1975

ACTA BIOQUIMICA CLINICA LATINOAMERICANA: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0; fully open access; review over 12 weeks (community reports); community-reported acceptance: easy; 27 articles a year; indexed in SCIE.

Impact factor0Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeover 12 weeksCommunity average
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year27LetPub annual count

Scope

Aims, scope and focus

ACTA BIOQUIMICA CLINICA LATINOAMERICANA is published by FEDERACION BIOQUIMICA PROVINCIA BUENOS AIRES and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Metabolism and Genetic Disorders, Health and Lifestyle Studies and Diabetes and associated disorders, together about 18.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Su especialidad es la Bioquímica Clínica orientada al estudio de las alteraciones bioquímicas de los humanos y de la incidencia del medio ambiente en la salud y en la enfermedad a través de los análisis bioquímico-clínicos.

From the journal's Aims & Scope

Research area (LetPub): MEDICAL LABORATORY TECHNOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology6.3%
  2. Health and Lifestyle StudiesHealth Professions6.3%
  3. Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6%
  4. Parasitic Infections and DiagnosticsImmunology and Microbiology5.8%
  5. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5.5%
  6. Clinical Laboratory Practices and Quality ControlMedicine5.5%
  7. Medical research and treatmentsMedicine5%
  8. Renal function and acid-base balanceMedicine4.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedical Laboratory TechnologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedical Laboratory TechnologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedical Laboratory TechnologyZone 4

Top journal: noReview journal: no

Database indexing

SCIELetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0LetPub ·
h-index
10OpenAlex ·
i10-index
11OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Volume

Articles per year
27LetPub ·

Articles by year OpenAlex count · 796 in total · the current year is incomplete

YearArticlesOpen accessCitations
2021200

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
FEDERACION BIOQUIMICA PROVINCIA BUENOS AIRES
Country or region
ARGENTINA
Language
Spanish
Frequency
Quarterly
Founded
1975
ISSN
0325-2957
Electronic ISSN
1851-6114
Official links

FAQ

Frequently asked questions about ACTA BIOQUIMICA CLINICA LATINOAMERICANA

What CAS zone is ACTA BIOQUIMICA CLINICA LATINOAMERICANA in?

In the 2025 upgraded edition of the CAS Journal Ranking, ACTA BIOQUIMICA CLINICA LATINOAMERICANA is in Zone 4 of Medicine, and in Zone 4 of the minor category Medical Laboratory Technology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of ACTA BIOQUIMICA CLINICA LATINOAMERICANA?

The latest impact factor listed by LetPub is 0; h-index 10.

How long does peer review take at ACTA BIOQUIMICA CLINICA LATINOAMERICANA?

Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index ACTA BIOQUIMICA CLINICA LATINOAMERICANA?

According to LetPub and DOAJ records, ACTA BIOQUIMICA CLINICA LATINOAMERICANA is indexed in SCIE.

Is ACTA BIOQUIMICA CLINICA LATINOAMERICANA open access, and what is the APC?

ACTA BIOQUIMICA CLINICA LATINOAMERICANA is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .